When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Síndrome de Wolff-Parkinson-White

最后审阅: 21 Aug 2025
最后更新: 24 Sep 2024

小结

定义

病史和体格检查

关键诊断因素

  • presencia de factores de riesgo
  • taquicardia por reentrada auriculoventricular (TRAV)
完整详情

其他诊断因素

  • palpitaciones
  • mareos
  • disnea
  • dolor torácico
  • fibrilación auricular
  • aleteo auricular
  • anomalías cardíacas congénitas
  • muerte cardíaca súbita
  • síncope y presíncope
  • taquicardia en el embarazo
完整详情

危险因素

  • Anomalía de Ebstein
  • cardiomiopatía hipertrófica
  • prolapso de la válvula mitral
  • comunicación interauricular
  • comunicación interventricular
  • transposición de los grandes vasos
  • coartación aórtica
  • dextrocardia
  • divertículos del seno coronario
  • aneurismas de la aurícula izquierda y derecha
  • rabdomiomas cardíacos
  • síndrome de Marfan
  • ataxia de Friedreich
  • antecedentes familiares
完整详情

诊断性检查

首要检查

  • electrocardiograma (ECG) de 12 derivaciones
完整详情

需考虑的检查

  • ecocardiograma
  • prueba de esfuerzo
  • estudio electrofisiológico
完整详情

治疗流程

初步治疗

inestable: presión arterial <90/60 mmHg, signos de hipoperfusión sistémica o fibrilación auricular inestable

急症处理

estable: taquicardia de complejo estrecho (ortodrómica de intercambio auriculoventricular)

estable: taquicardia de complejo ancho (antidrómica de intercambio auriculoventricular)

estable: taquicardia con preexcitación por fibrilación auricular o aleteo auricular

estable: taquicardia con preexcitación por taquicardia auricular

持续性治疗

tras tratamiento agudo: asintomático

tras tratamiento agudo: sintomático

撰稿人

作者

Hugh Calkins, MD

Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

利益声明

HC declares that he is a consultant for Medtronic, Biosense Webster, Abbott, and Boston Scientific.

鸣谢

We would like to acknowledge our cardiology expert panel member, Dr Fred Kusumoto, for his contribution to this topic.

Professor Hugh Calkins would like to gratefully acknowledge Dr David Frankel, Dr Mithilesh K. Das, and Dr Douglas P. Zipes, previous contributors to this topic.

利益声明

DF, MKD, and DPZ declare that they have no competing interests.

同行评议者

Nicolas Palaskas, MD, FACC

Assistant Professor

University of Texas MD Anderson Cancer Center

Houston

TX

利益声明

NP declares that he has no competing interests.

Joseph E. Marine, MD

Associate Professor of Medicine

Director of Electrophysiology

Johns Hopkins University School of Medicine

Baltimore

MD

利益声明

JEM declares that he has no competing interests.

Suneet Mittal, MD

Director

Electrophysiology Laboratory

The St. Luke's-Roosevelt Hospital Center

New York

NY

利益声明

SM declares that he has no competing interests.

Andrew Turley, MB ChB

Cardiology Specialist Registrar

The James Cook University Hospital

Middlesbrough

UK

利益声明

AT declares that he has no competing interests.

Steve Hsu, MD

Associate Professor

Department of Medicine

Division of Cardiology

University of Florida College of Medicine

Jacksonville

FL

利益声明

SH declares that he has no competing interests.

Peer reviewer acknowledgements

BMJ Best Practice topics are updated on a rolling basis in line with developments in evidence and guidance. The peer reviewers listed here have reviewed the content at least once during the history of the topic.

Disclosures

Peer reviewer affiliations and disclosures pertain to the time of the review.

参考文献

Our in-house evidence and editorial teams collaborate with international expert contributors and peer reviewers to ensure that we provide access to the most clinically relevant information possible.

关键文献

Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC). Eur Heart J. 2020 Feb 1;41(5):655-720.全文  摘要

Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126.全文  摘要

Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS guideline for the management of adult patients with supraventricular tachycardia: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2016;67:e27-e115.全文  摘要

参考文献

A full list of sources referenced in this topic is available to users with access to all of BMJ Best Practice.
  • Síndrome de Wolff-Parkinson-White images
  • Differentials

    • Vía auriculofascicular
    • Síndrome de Lown-Ganong-Levine
    • Vía nodofascicular
    More Differentials
  • Guidelines

    • 2023 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
    • 2022 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
    More Guidelines
  • Patient information

    Atrial fibrillation: what are the treatment options?

    Atrial fibrillation: what is it?

    More Patient information
  • padlock-lockedLog in or subscribe to access all of BMJ Best Practice

Use of this content is subject to our disclaimer